The new Alchemy - Converting Science and Wealth
Monash is committed to helping researchers commercialise leading edge science and technology projects.
Industry Engagement & Commercialisation: http://www.monash.edu/industryengagement/
Subscribe to Research eNews: http://www.monash.edu.au/enews/research/
|
|
- Information Page
Welcome to Master of Business (Science and Technology)
- About the Centre
Learn about the Centre's mission, activities and people
- Education / Commercialisation
Get information on Graduate Certificate, Masters and PhD programs involving the Centre
- Research
Find out about the areas of research interest of the Centre and details on specific research projects
- Wealth Creation
See some examples of activities in which the Centre is involved in creating wealth from science or interacting with commerce and industry
- Alumni
The Centre is proud of its Alumni and their achievements. Find information on the Centre's Alumni and their careers.
- Frequently Asked Questions
Click on the above link to have answered some common questions.
- Want to join our Wiki?
Email Kristine.Brown@swc.monash.edu.au to apply.
| Did you know? |
|
"Small, nimble biotechs are busy trolling through the reject piles of large pharmaceutical companies, aiming to do more quickly and cheaply what the giants have difficulty doing for themselves – taking a molecule through the critical experiments that will yield proof-of-concept information. A large pharma may spend 4 years and $40 million to reach clinical proof of concept; start-ups try to reach the same point for 50% of the time and 10% of the cost. The small companies claim they can achieve these results by avoiding bureaucracy and politics, allowing them to focus on swift, sharp experiments to identify the winners and eliminate the losers. The typical business model is to in-licence sidelined molecules for the biotech’s own pipeline, but another option is to return the molecule to the pharma, along with proof-of-concept data, in return for an up-front payment and future royalties."
|
|
|
News about the Centre
|
